Clinical Trial Update: The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of combining apatinib with etoposide in heavily pretreated patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Etoposide (Etoposide)

Snippet

Sponsor: Third Military Medical University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN